SARS-CoV-2 incidence, testing rates, and severe COVID-19 outcomes among people with and without HIV. (1st December 2021)

• Record Type: Journal Article
• Authors: Spinelli, Matthew A.; Brown, Lillian B.; Glidden, David V.; Hunter, Kyle; Martin-Tuite, Patrick; Zheng, James; Sera, Curtis; Havlir, Diane; Buchbinder, Susan P.; Gandhi, Monica
• Is Part Of: AIDS. Volume 35:Number 15(2021)
• Publication Date: 2021-12-01
• Subjects: AIDS (Disease) -- Periodicals; Acquired Immunodeficiency Syndrome; AIDS (Disease); Periodicals; Periodicals; 616.9792005
• DOI: 10.1097/QAD.0000000000003075
• Languages: English
• ISSNs: 0269-9370

Abstract

Abstract : N/A: To assess SARS-CoV-2 outcomes, we matched a municipal COVID-19 registry and clinic rosters from a municipal primary care network containing a large HIV clinic and assessed clinical outcomes by HIV status. The risk of severe COVID-19 was higher among people with HIV (PWH, adjusted relative risk = 1.84, 95% confidence interval = 1.05–3.25), while SARS-CoV-2 incidence was lower despite higher testing rates. SARS-CoV-2 vaccination campaigns should prioritize PWH to prevent severe COVID-19 disease given potentially higher risk.